0000899243-22-037275.txt : 20221201
0000899243-22-037275.hdr.sgml : 20221201
20221201160519
ACCESSION NUMBER: 0000899243-22-037275
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221129
FILED AS OF DATE: 20221201
DATE AS OF CHANGE: 20221201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Postma Robert W
CENTRAL INDEX KEY: 0001827847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 221438856
MAIL ADDRESS:
STREET 1: 141 MECOX ROAD
CITY: WATER MILL
STATE: NY
ZIP: 11976
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8030 EL RIO STREET
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: (346) 355-4099
MAIL ADDRESS:
STREET 1: 8030 EL RIO STREET
CITY: HOUSTON
STATE: TX
ZIP: 77054
FORMER COMPANY:
FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC
DATE OF NAME CHANGE: 20050919
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-29
0
0001107421
Alaunos Therapeutics, Inc.
TCRT
0001827847
Postma Robert W
C/O ALAUNOS THERAPEUTICS, INC.
8030 EL RIO ST.
HOUSTON
TX
77054
1
0
0
0
Common Stock
2022-11-29
4
P
0
750000
0.65
A
5000000
I
By WaterMill Asset Management Corp.
Common Stock
1241870
D
Common Stock
3574
I
By Spouse's IRA
The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp.
The shares were purchased in a registered underwritten offering on November 29, 2022.
Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
/s/ Melinda Lackey, Attorney-in-Fact
2022-12-01